Smart Medical Implant System with AI-Driven Personalized Treatment
Legal Citation
Summary of the Inventive Concept
A novel medical implant system that integrates an implantable medical drug delivery device with AI, IoT, blockchain, and nanomaterial technologies to provide personalized treatment, real-time monitoring, and optimized drug delivery rates.
Background and Problem Solved
The original patent addressed the limitation of initial drug 'burst' in existing drug implants. However, the new inventive concept takes a significant leap forward by synergistically combining the patented implantable medical drug delivery device with distinct technologies to create a more powerful system that provides personalized medical treatment, real-time monitoring, and optimized drug delivery rates.
Detailed Description of the Inventive Concept
The smart medical implant system consists of the implantable medical drug delivery device with a non-homogenous mixture of at least two different types of drug materials. This device is integrated with an AI-powered diagnostic module that analyzes patient data to optimize drug delivery rates. Additionally, the system incorporates an IoT-enabled sensor network to enable real-time monitoring of medical implant performance, and utilizes blockchain technology to securely store and analyze patient data. Furthermore, the system can include a nanomaterial-based coating for targeted drug release and a machine learning algorithm that predicts optimal drug delivery schedules. The AI-driven analytics module provides real-time feedback on drug delivery rates and patient response, enabling personalized treatment planning.
Novelty and Inventive Step
The new claims introduce a novel combination of the patented implantable medical drug delivery device with AI, IoT, blockchain, and nanomaterial technologies, providing a synergistic system that is more powerful and effective than the original patent. The inventive step lies in the integration of these distinct technologies to create a smart medical implant system that provides personalized treatment, real-time monitoring, and optimized drug delivery rates.
Alternative Embodiments and Variations
Alternative embodiments of the smart medical implant system could include variations in the AI-powered diagnostic module, such as using different machine learning algorithms or integrating with other diagnostic tools. The IoT-enabled sensor network could be replaced with other types of sensor technologies, and the blockchain technology could be substituted with other secure data storage solutions. The nanomaterial-based coating could be modified to target specific drug release profiles, and the machine learning algorithm could be adapted to predict optimal drug delivery schedules based on different patient data.
Potential Commercial Applications and Market
The smart medical implant system has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, remote patient monitoring, and optimized drug delivery. The system could be marketed to hospitals, clinics, and pharmaceutical companies, and could potentially disrupt the existing medical implant market by providing a more effective and efficient solution for patients.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0024 |
| A | A61 | A61K31/4468 |
| A | A61 | A61K31/485 |
| A | A61 | A61K45/06 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically implantable drug delivery systems with a focus on controlled drug release mechanisms, requiring expertise in materials science, pharmaceutical engineering, and biomedical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or pharmaceutical scientist with advanced degree, experience in medical device design, knowledge of drug delivery technologies, familiarity with materials engineering, and understanding of integration of electronic/digital technologies with medical implants
Obviousness Rationale
A person having ordinary skill would recognize that integrating digital technologies like AI, IoT, and blockchain with the existing medical implant drug delivery system represents a predictable extension of known technological convergence trends. The core drug delivery mechanism remains fundamentally consistent with the source patent, while the added technologies provide enhanced monitoring and personalization capabilities. These technological integrations would be considered routine optimization and system enhancement by a skilled practitioner in the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,671 |
|---|---|
| Title | Medical implant |